ORETON METHYL Drug Patent Profile
✉ Email this page to a colleague
When do Oreton Methyl patents expire, and when can generic versions of Oreton Methyl launch?
Oreton Methyl is a drug marketed by Schering and is included in one NDA.
The generic ingredient in ORETON METHYL is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oreton Methyl
A generic version of ORETON METHYL was approved as methyltestosterone by IMPAX LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORETON METHYL?
- What are the global sales for ORETON METHYL?
- What is Average Wholesale Price for ORETON METHYL?
Summary for ORETON METHYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Patent Applications: | 4,146 |
| DailyMed Link: | ORETON METHYL at DailyMed |
US Patents and Regulatory Information for ORETON METHYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | ORETON METHYL | methyltestosterone | TABLET;ORAL | 003158-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | ORETON METHYL | methyltestosterone | TABLET;ORAL | 003158-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
